Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term comparison of entecavir versus adefovir in HBeAg-negative chronic hepatitis B
ChiCTR-TNRC-11001737Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of entecavir and adefovir dipivoxil in Chronic Hepatitis B (CHB) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: HBV DNA, ALT and 2 more. Started Feb 2012; status: completed.
02
Drugs
entecaviradefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TNRC-11001737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNRC-11001737.